Additionally, although currently there is no available drug target to specifically treat ASD, it is worth trying in our rat model of ASD the antipsychotic drug risperidone, the first approved by the FDA to treat the common symptom of irritability in autism, and compare its effectiveness with EPO and zinc sulfate on iNOS as well as other other pre-specified parameters. Here, EPO is linked to autism.